Title | Type | SJR | H index | Total Docs. (2010) | Total Docs. (3years) | Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2010) | %Female (2010) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Handbook of Experimental Pharmacology | journal | 1.826 Q1 | 110 | 87 | 364 | 8617 | 1520 | 339 | 4.36 | 99.05 | 26.54 | |
2 | ChemMedChem | journal | 1.294 Q1 | 119 | 211 | 603 | 9609 | 2141 | 592 | 3.38 | 45.54 | 35.98 | |
3 | Marine Drugs | journal | 0.751 | 159 | 154 | 103 | 11747 | 393 | 102 | 3.74 | 76.28 | 41.75 | |
4 | Progress in Drug Research | book series | 0.648 Q1 | 46 | 0 | 33 | 0 | 105 | 30 | 3.90 | 0.00 | 0.00 | |
5 | Clinical and Translational Science | journal | 0.596 Q1 | 60 | 84 | 189 | 1424 | 187 | 121 | 0.99 | 16.95 | 36.05 | |
6 | Drug Metabolism and Personalized Therapy | journal | 0.468 Q1 | 38 | 6 | 49 | 264 | 106 | 47 | 2.08 | 44.00 | 35.00 | |
7 | Journal of Negative Results in BioMedicine | journal | 0.375 Q1 | 25 | 10 | 34 | 342 | 37 | 33 | 1.04 | 34.20 | 47.17 | |
8 | Advances in Antiviral Drug Design | book series | 0.320 Q2 | 12 | 0 | 7 | 0 | 6 | 6 | 0.00 | 0.00 | 0.00 | |
9 | Bioanalysis | journal | 0.298 Q2 | 70 | 176 | 128 | 6229 | 140 | 113 | 1.09 | 35.39 | 29.18 | |
10 | Expert Review of Clinical Pharmacology | journal | 0.218 Q2 | 60 | 68 | 129 | 5932 | 95 | 110 | 0.74 | 87.24 | 34.40 | |
11 | Handbook of Analytical Separations | book series | 0.181 Q2 | 13 | 0 | 32 | 0 | 7 | 0 | 0.22 | 0.00 | 0.00 | |
12 | Pharmacoeconomics - Spanish Research Articles | journal | 0.151 Q3 | 6 | 15 | 45 | 458 | 14 | 40 | 0.20 | 30.53 | 20.41 | |
13 | Pharmaceuticals Policy and Law | journal | 0.133 Q3 | 11 | 55 | 98 | 484 | 15 | 93 | 0.11 | 8.80 | 52.05 | |
14 | NATO Security through Science Series A: Chemistry and Biology | book series | 0.130 Q3 | 15 | 0 | 174 | 0 | 50 | 173 | 0.46 | 0.00 | 0.00 | |
15 | European Pharmaceutical Journal | journal | 0.121 Q3 | 9 | 12 | 21 | 336 | 4 | 19 | 0.19 | 28.00 | 53.57 | |
16 | European Pharmaceutical Review | trade journal | 0.120 Q3 | 9 | 43 | 29 | 799 | 4 | 23 | 0.14 | 18.58 | 18.84 | |
17 | Alimentary Pharmacology and Therapeutics Symposium Series | journal | 0.118 Q3 | 8 | 0 | 12 | 0 | 1 | 12 | 0.00 | 0.00 | 0.00 | |
18 | EJHP Practice | trade journal | 0.117 Q3 | 6 | 73 | 148 | 718 | 13 | 102 | 0.09 | 9.84 | 44.80 | |
19 | Botulinum Journal | journal | 0.114 Q4 | 6 | 8 | 8 | 292 | 3 | 6 | 0.38 | 36.50 | 21.05 | |
20 | Quality Assurance Journal | journal | 0.109 Q4 | 11 | 11 | 47 | 73 | 11 | 39 | 0.10 | 6.64 | 25.93 | |
21 | Arzneimitteltherapie | journal | 0.105 Q4 | 6 | 138 | 300 | 1195 | 11 | 123 | 0.04 | 8.66 | 40.00 | |
22 | Drug Target Insights | journal | 0.103 Q4 | 16 | 0 | 15 | 0 | 3 | 15 | 0.20 | 0.00 | 0.00 | |
23 | European Life Science Journal | trade journal | 0.100 Q4 | 1 | 35 | 86 | 3 | 1 | 85 | 0.01 | 0.09 | 10.71 | |
24 | Life Science Clusters | trade journal | 0.100 Q4 | 0 | 11 | 60 | 0 | 0 | 55 | 0.00 | 0.00 | 37.50 | |
25 | Pharmaceutical Manufacturing and Packing Sourcer | trade journal | 0.100 Q4 | 3 | 67 | 71 | 246 | 1 | 71 | 0.01 | 3.67 | 15.85 | |
26 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 7 | 4 | 518 | 0 | 4 | 0.00 | 74.00 | 31.25 | ||
27 | Antibiotics | journal | 77 | 1 | 0 | 140 | 0 | 0 | 0.00 | 140.00 | 100.00 | ||
28 | F1000 Biology Reports | journal | 32 | 88 | 0 | 2780 | 0 | 0 | 0.00 | 31.59 | 27.11 | ||
29 | Journal of Pharmaceutical Health Services Research | journal | 19 | 29 | 0 | 763 | 0 | 0 | 0.00 | 26.31 | 50.65 | ||
30 | Journal of Pharmaceutical Policy and Practice | journal | 32 | 15 | 0 | 260 | 0 | 0 | 0.00 | 17.33 | 48.48 | ||
31 | Molecular and Cellular Toxicology | journal | 28 | 50 | 0 | 1499 | 0 | 0 | 0.00 | 29.98 | 46.31 | ||
32 | PharmacoVigilance Review | journal | 2 | 23 | 0 | 66 | 0 | 0 | 0.00 | 2.87 | 40.00 | ||
33 | Regulatory Rapporteur | trade journal | 7 | 76 | 0 | 360 | 0 | 0 | 0.00 | 4.74 | 49.45 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®